DK0538897T3 - Anvendelse af BMY 14802 ved behandling af angst hos benzodiazepinseponerede patienter - Google Patents
Anvendelse af BMY 14802 ved behandling af angst hos benzodiazepinseponerede patienterInfo
- Publication number
- DK0538897T3 DK0538897T3 DK92118219.2T DK92118219T DK0538897T3 DK 0538897 T3 DK0538897 T3 DK 0538897T3 DK 92118219 T DK92118219 T DK 92118219T DK 0538897 T3 DK0538897 T3 DK 0538897T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- bmy
- benzodiazepine
- anxiety
- exposed patients
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78201091A | 1991-10-24 | 1991-10-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0538897T3 true DK0538897T3 (da) | 1997-08-25 |
Family
ID=25124656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92118219.2T DK0538897T3 (da) | 1991-10-24 | 1992-10-23 | Anvendelse af BMY 14802 ved behandling af angst hos benzodiazepinseponerede patienter |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5278164A (es) |
| EP (1) | EP0538897B1 (es) |
| JP (1) | JPH05238934A (es) |
| KR (1) | KR100196334B1 (es) |
| AT (1) | ATE150645T1 (es) |
| AU (1) | AU649169B2 (es) |
| CA (1) | CA2081062A1 (es) |
| CY (1) | CY2019A (es) |
| DE (1) | DE69218544T2 (es) |
| DK (1) | DK0538897T3 (es) |
| ES (1) | ES2101000T3 (es) |
| GR (1) | GR3022945T3 (es) |
| HK (1) | HK113897A (es) |
| IL (1) | IL103499A0 (es) |
| OA (1) | OA09766A (es) |
| PH (1) | PH30028A (es) |
| TW (1) | TW217382B (es) |
| ZA (1) | ZA928105B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011091418A1 (en) * | 2010-01-25 | 2011-07-28 | Northeastern University | Screening method for adverse side effects of a therapeutic pharmaceutical drug |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4605655A (en) * | 1984-03-06 | 1986-08-12 | Bristol-Myers Company | Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives |
| US5055470A (en) * | 1989-06-01 | 1991-10-08 | Bristol-Myers Squibb Co. | Method of treatment of ischemia in brain |
-
1992
- 1992-10-21 CA CA002081062A patent/CA2081062A1/en not_active Abandoned
- 1992-10-21 IL IL103499A patent/IL103499A0/xx unknown
- 1992-10-21 TW TW081108399A patent/TW217382B/zh active
- 1992-10-21 AU AU27165/92A patent/AU649169B2/en not_active Ceased
- 1992-10-22 PH PH45145A patent/PH30028A/en unknown
- 1992-10-22 ZA ZA928105A patent/ZA928105B/xx unknown
- 1992-10-22 OA OA60291A patent/OA09766A/en unknown
- 1992-10-22 JP JP4324571A patent/JPH05238934A/ja not_active Ceased
- 1992-10-23 DE DE69218544T patent/DE69218544T2/de not_active Expired - Fee Related
- 1992-10-23 DK DK92118219.2T patent/DK0538897T3/da active
- 1992-10-23 KR KR1019920019562A patent/KR100196334B1/ko not_active IP Right Cessation
- 1992-10-23 ES ES92118219T patent/ES2101000T3/es not_active Expired - Lifetime
- 1992-10-23 EP EP92118219A patent/EP0538897B1/en not_active Expired - Lifetime
- 1992-10-23 AT AT92118219T patent/ATE150645T1/de not_active IP Right Cessation
-
1993
- 1993-06-01 US US08/069,654 patent/US5278164A/en not_active Expired - Lifetime
-
1997
- 1997-03-27 GR GR970400379T patent/GR3022945T3/el unknown
- 1997-06-26 HK HK113897A patent/HK113897A/xx not_active IP Right Cessation
-
1998
- 1998-02-20 CY CY201998A patent/CY2019A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US5278164A (en) | 1994-01-11 |
| DE69218544D1 (de) | 1997-04-30 |
| DE69218544T2 (de) | 1997-11-13 |
| ZA928105B (en) | 1993-08-25 |
| EP0538897B1 (en) | 1997-03-26 |
| IL103499A0 (en) | 1993-03-15 |
| PH30028A (en) | 1996-11-08 |
| JPH05238934A (ja) | 1993-09-17 |
| OA09766A (en) | 1993-11-30 |
| AU649169B2 (en) | 1994-05-12 |
| AU2716592A (en) | 1993-04-29 |
| ATE150645T1 (de) | 1997-04-15 |
| CY2019A (en) | 1998-02-20 |
| ES2101000T3 (es) | 1997-07-01 |
| EP0538897A1 (en) | 1993-04-28 |
| GR3022945T3 (en) | 1997-06-30 |
| KR930007452A (ko) | 1993-05-20 |
| HK113897A (en) | 1997-08-29 |
| TW217382B (es) | 1993-12-11 |
| CA2081062A1 (en) | 1993-04-25 |
| KR100196334B1 (ko) | 1999-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT63564A (en) | Medical preparatives, method for producing them and their applications as analgetic and/or febrifuge in human and veterinary medicine | |
| DE69333607D1 (de) | Vorrichtung zur Herstellung von vorgefüllten, sterilen Abgabevorrichtungen | |
| DE69132688D1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
| KR950002785A (ko) | 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜 | |
| DE69019716D1 (de) | Medizinisches Gerät zur Laserbehandlung. | |
| DK0713701T3 (da) | 2-Brommelatonin til behandling af søvnforstyrrelser | |
| DK0723444T3 (da) | Levobupivacain, som er egnet til behandling af kronisk smerte | |
| DE69202019D1 (de) | Verwendung von essentiellen Fettsäuren zur Herstellung eines Arzneimittels zur Behandlung von AIDS. | |
| DK0499923T3 (da) | Dentaladhæsiv | |
| DK0998287T3 (da) | Anvendelse af levobupivacain | |
| ATE191849T1 (de) | Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst | |
| DK0652000T3 (da) | Anvendelse af 2-phenyl-3-aroylbenzothiophener til fremstilling af et lægemiddel til inhibering af angiogenese og angiogene sygdomme | |
| DK0981347T3 (da) | Anvendelsen af levobupivacain i ansigtkirurgi | |
| DK0655243T3 (da) | Melatoninderivater til anvendelse ved behandling af søvnlidelser | |
| DK0476113T3 (da) | Lægemiddel til behandling af hyperlipidæmi og/eller atherosklerose | |
| DK0538897T3 (da) | Anvendelse af BMY 14802 ved behandling af angst hos benzodiazepinseponerede patienter | |
| ATE147978T1 (de) | Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit | |
| SE9101341D0 (sv) | New medicinal use | |
| DK0711163T3 (da) | Anvendelse af benzydamin i behandlingen af patologiske tilstande forårsaget af TNF | |
| DE69228235D1 (de) | Verwendung eines Mittels zur Herstellung eines Arzneimittels zur Behandlung von Lebererkrankung | |
| SE9403861D0 (sv) | Novel medicinal use | |
| EE04951B1 (et) | R-(+)-alfa-(2,3-dimetoksfenl)-1-[2-(4-fluorofenl)etl]-4-piperidiinmetanooli kasutamine unehirete raviks | |
| ES1019006Y (es) | Jeringa de anestesia dental desechable. | |
| DK0495721T3 (da) | Anvendelsen af et polypeptid med en humant-interleukin-2-aktivitet til fremstilling af farmaceutiske præparater beregnet til behandling af pneumothorax | |
| IT9048106A0 (it) | Associazione medicamentosa per il trattamento dell'ipertensione e dell'insufficienza cardiaca congestiva. (caso 100-7516) |